P. Noble

Therapeutic Targeting of Lewisy and Lewisb with a Novel Monoclonal Antibody 692/29

S. Harding, L. Durrant, I. Spendlove, 2013, PloS one.

The Role of Hyaluronan Degradation Products as Innate Alloimmune Agonists

B. Tesar, D. Goldstein, S. Palmer, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Characterisation of anti-glycan monoclonal antibodies

P. Noble, Philip W. Noble, 2011 .

Optimizing a lupus autoantibody for targeted cancer therapy.

R. Weisbart, J. Hansen, G. Chan, 2015, Cancer research.

cGAS-activating lupus autoantibody for cancer immunotherapy

Jiangbing Zhou, J. Gera, J. Hansen, 2023, bioRxiv.

DNA-damaging autoantibodies and cancer: the lupus butterfly theory

D. Isenberg, S. Bernatsky, R. Ramsey‐Goldman, 2016, Nature Reviews Rheumatology.

High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival

J. Scholefield, A. Al-Attar, S. Durrant, 2013, British Journal of Cancer.

A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors

Jiangbing Zhou, C. García, Zhangyong Hong, 2016, Oncotarget.

A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells

S. Bernatsky, R. Weisbart, J. Hansen, 2014, Scientific Reports.

DNA-dependent targeting of cell nuclei by a lupus autoantibody

P. Glazer, Yanfeng Liu, R. Weisbart, 2015, Scientific Reports.

Optimizing a lupus autoantibody for targeted cancer therapy.

R. Weisbart, J. Hansen, G. Chan, 2015, Cancer Research.